Home > Animal Health & Nutrition > Veterinary CRO and CDMO Market > Table of Contents

Veterinary CRO and CDMO Market – By Animal Type (Companion, Livestock), Service Type (CRO, [Clinical Trials, Quality Assurance], CDMO [Manufacturing, Development, Packaging & Labelling]), Product (Drugs, Biologics) – Global Forecast 2024 – 2032

  • Report ID: GMI10318
  • Published Date: Jul 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Increasing pet ownership and spending

3.2.1.2    Expanding veterinary outsourcing services

3.2.1.3    Increasing zoonotic disease

3.2.1.4    Rising spending on development and research

3.2.2    Industry pitfalls & challenges

3.2.2.1    Lack of standardization in veterinary CRO

3.2.2.2    Regulatory challenges and high initial investment costs

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Future market trends

3.6    Porter's analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Companion animals

5.3    Livestock animals

Chapter 6   Market Estimates and Forecast, By Service Type, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    CRO services

6.2.1    Clinical trials

6.2.2    Toxicology

6.2.3    Quality assurance

6.2.4    Regulatory services

6.2.5    Other CRO services

6.3    CDMO services

6.3.1    Manufacturing

6.3.2    Development

6.3.3    Packaging & labeling

6.3.4    Market approval & post-marketing

6.3.5    Other CDMO services

Chapter 7   Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Drugs

7.3    Biologics

7.4    Medicated feed and supplements

Chapter 8   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.3.6    The Netherlands

8.3.7    Rest of Europe

8.4    Asia Pacific

8.4.1    Japan

8.4.2    China

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Rest of Latin America

8.6    Middle East and Africa

8.6.1    Saudi Arabia

8.6.2    South Africa

8.6.3    UAE

8.6.4    Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    Argenta Holdco Limited

9.2    Clinvet

9.3    Eva Pharma

9.4    Huvepharma

9.5    IDEXX Laboratories, Inc.

9.6    KLIFOVET GmbH

9.7    löhlein and wolf vet research

9.8    Mercurio HoldCo Limited

9.9    Moredun Foundation

9.10    Syngene International Limited

9.11    Tekro Ltd.

9.12    Triveritas

9.13    Uniivo

9.14    Vetio

   

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 304
  • Countries covered: 22
  • Pages: 130
 Download Free Sample